Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Cash & Current Investments (2018 - 2025)

Dna X filings provide 8 years of Cash & Current Investments readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 83.79% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 83.79% decrease, with the full-year FY2025 number at $1.3 million, down 83.79% from a year prior.
  • Cash & Current Investments hit $1.3 million in Q4 2025 for Dna X, down from $4.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $13.9 million in Q1 2021 to a low of $101000.0 in Q1 2024.
  • Median Cash & Current Investments over the past 5 years was $5.2 million (2025), compared with a mean of $5.8 million.
  • Biggest five-year swings in Cash & Current Investments: crashed 98.95% in 2024 and later skyrocketed 5235.29% in 2025.
  • Dna X's Cash & Current Investments stood at $12.3 million in 2021, then rose by 7.65% to $13.2 million in 2022, then plummeted by 97.74% to $299000.0 in 2023, then surged by 2588.96% to $8.0 million in 2024, then plummeted by 83.79% to $1.3 million in 2025.
  • The last three reported values for Cash & Current Investments were $1.3 million (Q4 2025), $4.3 million (Q3 2025), and $5.4 million (Q2 2025) per Business Quant data.